Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MODD Modular Medical	$0.74 -0.1%	$0.72	$0.63 ▼ $2.65	$40.96M	0.17	84,007 shs	32,952 shs
NMTC NeuroOne Medical Technologies	$0.74 -1.5%	$0.77	$0.40 ▼ $1.39	$37.50M	0.68	296,886 shs	126,452 shs
POAI Predictive Oncology	$0.92 +0.1%	$0.83	$0.55 ▼ $3.06	$9.95M	1.18	172,260 shs	60,767 shs
RBOT Vicarious Surgical	$6.32 -3.8%	$8.50	$5.00 ▼ $19.00	$38.96M	1.41	36,182 shs	24,099 shs

Reduce the Risk

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MODD Modular Medical	-1.24%	+4.44%	+5.86%	-16.08%	-59.29%
NMTC NeuroOne Medical Technologies	-2.70%	-0.17%	-11.97%	+17.50%	-5.30%
POAI Predictive Oncology	+2.69%	+1.54%	+14.24%	+0.43%	+0.86%
RBOT Vicarious Surgical	-0.26%	+11.20%	-32.78%	-15.71%	-6.23%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
MODD Modular Medical	0.4363 of 5 stars	0.0	3.0	1.9	1.7	0.0
NMTC NeuroOne Medical Technologies	2.7059 of 5 stars	3.5	5.0	3.3	0.0	0.0
POAI Predictive Oncology	0.5048 of 5 stars	0.0	3.0	2.6	0.0	0.6
RBOT Vicarious Surgical	1.1742 of 5 stars	2.0	2.0	1.4	2.5	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
MODD Modular Medical	0.00	N/A	N/A	N/A
NMTC NeuroOne Medical Technologies	3.00	Buy	$1.45	96.24% Upside
POAI Predictive Oncology	2.00	Hold	N/A	N/A
RBOT Vicarious Surgical	2.00	Hold	$7.00	10.74% Upside

Current Analyst Ratings Breakdown

Latest POAI, RBOT, MODD, and NMTC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
8/13/2025	RBOT Vicarious Surgical	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$8.50 ➝ $7.00

(Data available from 8/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
MODD Modular Medical	N/A	N/A	N/A	N/A	$0.21 per share	N/A
NMTC NeuroOne Medical Technologies	$3.45M	10.71	N/A	N/A	$0.16 per share	4.62
POAI Predictive Oncology	$1.62M	6.15	N/A	N/A	($0.15) per share	-6.10
RBOT Vicarious Surgical	N/A	N/A	N/A	N/A	$3.89 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
MODD Modular Medical	-$18.82M	-$0.51	0.00	∞	N/A	N/A	-185.60%	-158.95%	11/12/2025 (Estimated)
NMTC NeuroOne Medical Technologies	-$12.32M	-$0.15	N/A	∞	N/A	-55.44%	-163.49%	-78.67%	N/A
POAI Predictive Oncology	-$12.66M	-$3.05	N/A	N/A	N/A	-587.31%	-722.01%	-167.23%	11/11/2025 (Estimated)
RBOT Vicarious Surgical	-$63.22M	-$10.09	0.00	N/A	N/A	N/A	-148.14%	-98.07%	11/11/2025 (Estimated)

Latest POAI, RBOT, MODD, and NMTC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2025	Q1 2026	MODD Modular Medical	-$0.10	-$0.12	-$0.02	-$0.12	$0.20 million	N/A
8/14/2025	Q3 2025	NMTC NeuroOne Medical Technologies	-$0.05	-$0.03	+$0.02	-$0.03	$1.82 million	$1.70 million
8/13/2025	Q2 2025	POAI Predictive Oncology	-$0.09	-$0.22	-$0.13	-$0.23	$1.50 million	$0.00 million
8/12/2025	Q2 2025	RBOT Vicarious Surgical	-$2.61	-$2.23	+$0.38	-$2.23	N/A	N/A
6/20/2025	Q4 2025	MODD Modular Medical	-$0.11	-$0.12	-$0.01	-$0.12	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
MODD Modular Medical	N/A	N/A	N/A	N/A	N/A
NMTC NeuroOne Medical Technologies	N/A	N/A	N/A	N/A	N/A
POAI Predictive Oncology	N/A	N/A	N/A	N/A	N/A
RBOT Vicarious Surgical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
MODD Modular Medical	N/A	4.04	4.04
NMTC NeuroOne Medical Technologies	N/A	7.13	5.80
POAI Predictive Oncology	N/A	0.32	0.31
RBOT Vicarious Surgical	N/A	5.11	5.11

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
MODD Modular Medical	27.47%
NMTC NeuroOne Medical Technologies	16.07%
POAI Predictive Oncology	9.04%
RBOT Vicarious Surgical	47.27%

Insider Ownership

Company	Insider Ownership
MODD Modular Medical	20.46%
NMTC NeuroOne Medical Technologies	8.90%
POAI Predictive Oncology	3.44%
RBOT Vicarious Surgical	11.99%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
MODD Modular Medical	20	55.28 million	43.97 million	Not Optionable
NMTC NeuroOne Medical Technologies	20	50.00 million	45.55 million	Optionable
POAI Predictive Oncology	30	10.89 million	10.52 million	Not Optionable
RBOT Vicarious Surgical	210	5.93 million	5.22 million	No Data

POAI, RBOT, MODD, and NMTC Headlines

Recent News About These Companies

Vicarious Surgical to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

1 hour ago | tmcnet.com

Vicarious Surgical (NYSE:RBOT) Director Sells $18,445.10 in Stock

August 28 at 8:57 AM | insidertrades.com

Vicarious Surgical Faces Setback as Human Trials for Surgical Robot Are Delayed

August 25 at 8:39 AM | aktiencheck.deA

Donald Tang Sells 2,059 Shares of Vicarious Surgical (NYSE:RBOT) Stock

August 22, 2025 | insidertrades.com

Robotic surgery heats up with clearances and clinical trials

August 20, 2025 | crainsnewyork.comC

Vicarious Surgical (NYSE:RBOT) Given New $7.00 Price Target at Piper Sandler

August 15, 2025 | marketbeat.com

Vicarious Surgical (NYSE:RBOT) Announces Quarterly Earnings Results, Beats Expectations By $0.38 EPS

August 14, 2025 | marketbeat.com

Vicarious Surgical’s Earnings Call: Progress Amid Challenges

August 14, 2025 | msn.com

Vicarious Surgical delays robot clinical timeline

August 14, 2025 | finance.yahoo.com

Vicarious Surgical’s new CEO pushes back robot development timeline

August 14, 2025 | fiercebiotech.comF

Vicarious Surgical delays robot timeline

August 14, 2025 | finance.yahoo.com

Vicarious Surgical pushes back surgical robot timeline again

August 13, 2025 | massdevice.com

Vicarious Surgical Inc. (NYSE:RBOT) Q2 2025 Earnings Call Transcript

August 13, 2025 | msn.com

Vicarious Surgical Reports Improved Q2 Financials and Leadership Change

August 13, 2025 | msn.com

Vicarious Surgical Inc. (RBOT) Q2 2025 Earnings Call Transcript

August 12, 2025 | seekingalpha.com

Vicarious Surgical anticipates FY25 cash burn of about $50M

August 12, 2025 | msn.com

Vicarious Surgical reports Q2 EPS ($2.23), consensus ($2.50)

August 12, 2025 | msn.com

Vicarious Surgical Reports Second Quarter 2025 Financial Results

August 12, 2025 | businesswire.com

Vicarious Surgical (NYSE:RBOT) Stock Price Down 4.4% - What's Next?

August 8, 2025 | marketbeat.com

Vicarious Surgical (RBOT) to Release Quarterly Earnings on Tuesday

August 6, 2025 | marketbeat.com

Vicarious Surgical names Stephen From as next CEO

August 2, 2025 | medtechdive.comM

New MarketBeat Followers Over Time

Media Sentiment Over Time

POAI, RBOT, MODD, and NMTC Company Descriptions

Modular Medical NASDAQ:MODD

$0.74 0.00 (-0.09%)

Closing price 04:00 PM Eastern

Extended Trading

$0.78 +0.04 (+5.36%)

As of 06:40 PM Eastern

Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.

NeuroOne Medical Technologies NASDAQ:NMTC

$0.74 -0.01 (-1.48%)

Closing price 04:00 PM Eastern

Extended Trading

$0.79 +0.05 (+6.78%)

As of 08:00 PM Eastern

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.

Predictive Oncology NASDAQ:POAI

$0.92 +0.00 (+0.12%)

Closing price 03:59 PM Eastern

Extended Trading

$0.91 -0.01 (-0.87%)

As of 07:56 PM Eastern

Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples. It operates through four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment provides services that include the application of AI, collaboration projects, and clinical testing. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using a self-contained automated system that conducts self-interaction chromatography screens using additives and excipients included in protein formulations resulting in soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Eagan, Minnesota.

Vicarious Surgical NYSE:RBOT

$6.32 -0.25 (-3.79%)

Closing price 03:59 PM Eastern

Extended Trading

$6.40 +0.08 (+1.33%)

As of 07:46 PM Eastern

Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time